Illumina, Inc. (ILMN)
204.88
-1.57
(-0.76%)
USD |
NASDAQ |
Sep 14, 10:10
Illumina Free Cash Flow : 511.00M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 511.00M |
| March 31, 2026 | 556.00M |
| December 31, 2025 | 921.00M |
| September 30, 2025 | 993.00M |
| June 30, 2025 | 943.00M |
| March 31, 2025 | 788.00M |
| December 31, 2024 | 628.00M |
| September 30, 2024 | 465.00M |
| June 30, 2024 | 356.00M |
| March 31, 2024 | 365.00M |
| December 31, 2023 | 281.00M |
| September 30, 2023 | 168.00M |
| June 30, 2023 | -224.00M |
| March 31, 2023 | -228.00M |
| December 31, 2022 | -74.00M |
| September 30, 2022 | 79.00M |
| June 30, 2022 | 53.00M |
| March 31, 2022 | 208.00M |
| December 31, 2021 | 337.00M |
| September 30, 2021 | 469.00M |
| June 30, 2021 | 898.00M |
| March 31, 2021 | 890.00M |
| December 31, 2020 | 891.00M |
| September 30, 2020 | 933.00M |
| June 30, 2020 | 1.046B |
| Date | Value |
|---|---|
| March 31, 2020 | 941.00M |
| December 31, 2019 | 842.00M |
| September 30, 2019 | 691.00M |
| June 30, 2019 | 701.00M |
| March 31, 2019 | 823.00M |
| December 31, 2018 | 846.00M |
| September 30, 2018 | 829.00M |
| June 30, 2018 | 754.00M |
| March 31, 2018 | 645.00M |
| December 31, 2017 | 565.00M |
| September 30, 2017 | 545.62M |
| June 30, 2017 | 474.30M |
| March 31, 2017 | 514.54M |
| December 31, 2016 | 415.86M |
| September 30, 2016 | 422.01M |
| June 30, 2016 | 491.86M |
| March 31, 2016 | 472.44M |
| December 31, 2015 | 516.35M |
| September 30, 2015 | 387.80M |
| June 30, 2015 | 346.95M |
| March 31, 2015 | 371.83M |
| December 31, 2014 | 359.06M |
| September 30, 2014 | 373.87M |
| June 30, 2014 | 327.39M |
| March 31, 2014 | 247.41M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Thermo Fisher Scientific, Inc. | 7.318B |
| Agilent Technologies, Inc. | 1.267B |
| Danaher Corp. | 5.466B |
| Pacific Biosciences of California, Inc. | -130.48M |
| Bio-Rad Laboratories, Inc. | 353.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 201.00M |
| Cash from Investing (Quarterly) | -122.00M |
| Cash from Financing (Quarterly) | -129.00M |
| Free Cash Flow Per Share (Quarterly) | 1.039 |
| Free Cash Flow to Equity (Quarterly) | 176.00M |
| Free Cash Flow to Firm (Quarterly) | 178.11M |
| Free Cash Flow Yield | 1.62% |